文档介绍:β2微球蛋白在糖尿病肾病诊断中的价值
(作者:___________单位: ___________邮编: ___________)
【摘要】目的探讨血清β2微球蛋白(β2MG)和尿β2微球蛋白与2型糖尿病肾病的关系。方法采用免疫比浊法检测98例2型糖尿病患者和对照组38名健康者血清和尿β2MG,在98例糖尿病患者中早期糖尿病肾病50例(DN组),糖尿病未出现肾损害48例(NDN组)。结果糖尿病肾病组血清和尿β2MG与对照组之间差别均有统计学意义(),糖尿病未出现肾损害组与对照组相比,血清β2微球蛋白差别没有统计学意义(),尿β2微球蛋白差别具有统计学意义()。结论检测血清和尿β2微球蛋白早期诊断糖尿病肾病有良好的诊断价值。
【关键词】β2微球蛋白;糖尿病肾病;血清;尿
Abstract: Objective To explore the correlation between serumal and urinary β2microglobulin(β2MG) in patients with diabetic nephropathy. Methods Immunoturbidimetry was used to measure β2MG in serum and urine from 98 patients with type 2 diabetes and 38 normal patients. Among 98 cases of diabetes, 50 cases were diabetic nephropathy while the other 40 cases were Serumal
and urinary β2MG were significantly elevated in patients with diabetic pared with those in normal patients () No marked difference of serumal β2MG was detected but significant differences of urinary β2MG were found between nonnephropathy diabetes and normal persons (). Conclusion Measuring serumal and urinary β2MG is valuable to the diagnosis of diabetic nephropathy.
Keywords: β2microglobulin; diabetic nephropathy; serum; urine
目前20%~50%的2型糖尿病患者发生糖尿病肾病(diabetic nephropathy,DN),已成终末期肾病发生的主要原因。对糖尿病肾病患者及早进行诊断并且适当干预治疗,可能使肾脏病变发生逆转,这对控制糖尿病患者的病情发展具有重要的意义。血、尿β2微球蛋白(β2MG)作为糖尿病肾病早期敏感指标已被普遍认识,但血、尿β2MG检测在DN中的临床应用价值报道不多[1]。我们检测98例2型糖